Lipocine Inc. - Common Stock —— 季度财务数据 (NASDAQ:LPCN) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 1.7 M-1.97 M-1.89 M-2.99 M-2.92 M-2.26 M -10.05 M 投资活动产生的现金 761.06 K-882.07 K4.5 M701.45 K1.57 M-9.9 M -3.13 M 融资活动产生的现金 0075.62 K141.33 K2.65 M11.97 M 14.84 M 自由现金流 1.7 M-1.97 M-1.89 M-2.99 M-2.92 M-2.26 M -10.05 M

新闻

Lipocine (LPCN) Reports Q1 Loss, Beats Revenue Estimates

BioCryst Pharmaceuticals (BCRX) Reports Q1 Loss, Beats Revenue Estimates

美国股市涨跌不一；截至收盘道琼斯工业平均指数下跌0.13%

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.13%

Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock?

Relay Therapeutics, Inc. (RLAY) Reports Q4 Loss, Lags Revenue Estimates

Lipocine completes patient visits in phase 3 trial for PPD treatment

H.C. Wainwright上调Lipocine目标股价至15美元，因PPD试验进展

H.C. Wainwright raises Lipocine stock price target to $15 on PPD trial progress

Lipocine completes enrollment in phase 3 trial for PPD treatment

利波辛公司产后抑郁症药物试验在安全性评估后继续进行

Lipocine’s PPD drug trial continues after positive safety review